Shamburg News · 8-K filed Nov 10, 2026, 4:03 PM EST

Bionano Genomics Reports Third Quarter 2026 Results and Reiterates Full Year Revenue Guidance

BNGO · Bionano Genomics, Inc.

  • Earnings
  • Materiality: high

On November 10, 2026, Bionano Genomics reported third quarter 2026 results, with total revenue of $8.3 million, up 12% from $7.4 million a year earlier. Operating expenses decreased 12% to $10.5 million, and adjusted operating expense decreased 9% to $8.8 million. The company reiterated full year 2026 revenue guidance in the range of $31 to $33 million.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Item 2.02, accession 0001411690-26-000058.

Written from the filing by Shamburg Markets. Figures are as reported by the company.